Insider Shareholders with Direct Ownership of Metagenomi, Inc. (MGX)
This section provides a comprehensive overview of the insiders with direct ownership of Metagenomi, Inc. (MGX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Metagenomi, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Bayer Healthcare Llc
> 10% Shareholder |
4,050,997 | 0 | 4,050,997 | 1 |
Feb 13, 2024
Added 11.18%
|
Brian C. Thomas
Chief Executive Officer |
150,992 | 10,785 | 2,517,491 | 3 |
Jun 06, 2025
Reduced 0.43%
|
Novo Holdings
> 10% Shareholder |
1,739,175 | 0 | 1,739,175 | 2 |
Feb 13, 2024
Added 31.51%
|
93,471 | 6,390 | 315,543 | 3 |
Jun 06, 2025
Reduced 1.98%
|
|
11,552 | 0 | 122,664 | 1 |
Apr 01, 2024
Added 8.61%
|
|
Sarah B. Noonberg
Chief Medical Officer |
71,763 | 5,239 | 109,135 | 3 |
Jun 06, 2025
Reduced 4.58%
|
6,931 | 0 | 93,892 | 1 |
Apr 01, 2024
Added 6.87%
|
|
Pamela Wapnick
Chief Financial Officer |
83,316 | 11,208 | 72,108 | 6 |
Jun 06, 2025
Reduced 2.14%
|
Luis Borges
Chief Scientific Officer |
69,316 | 0 | 69,316 | 1 |
Apr 01, 2024
Added 50.0%
|
17,822 | 1,129 | 16,693 | 4 |
Jun 06, 2025
Reduced 1.18%
|
|
513,004 | 0 | 0 | 1 |
N/A
|